BERLIN, Germany, April 14, 2021 – LINK Medical, the Northern European clinical research organization (CRO), is continuing the expansion of its German presence. This further strengthens their position as a gateway between the Nordics and one of the largest medical device and pharmaceutical markets in Europe. By establishing a stronger position in Germany, LINK Medical’s global clients get access to Germany’s well-recognized regulatory authorities, its vast network of clinical trial sites and investigators, and Europe’s largest patient population – all key elements for performing high-quality clinical trials.
LINK Medical provides a full range of product development services for the pharmaceutical and medical device industries. With offices across the Nordic countries, Germany and the UK, LINK Medical operates as a single source of expertise to support clients located all over the world.
LINK Medical’s German office was established in 2015 and since then has expanded into a strong and dynamic team currently covering Medical Device Consultancy, Clinical Operations and Regulatory Services. All team members work with experienced and established companies that know exactly what they want on well-defined projects as well as with start-ups who often need broader, step-by-step guidance for bringing their innovation from concept stage to market. An important Clinical Operations group of experts, apart from Project Management and Monitoring, is the Start-up group that supports clients globally in achieving a rapid study start, saving resources and time. As a matrix organization with a global perspective, these capabilities radiate across LINK Medical to support customers across Northern Europe and beyond.
The strengthening of LINK Medical’s German team also include the recent appointment of a German-based Medical Device Director, Erwin de Buijzer MD, MBA, enabling LINK Medical to continue growing its leading medical device services and capabilities in Germany, in particular focusing on digital health. With a leadership background in the medical device sector, as well as a business education and experience as a medical doctor, Mr. de Buijzer brings considerable medical device expertise to LINK Medical and the German team. Erwin’s addition will build upon the team’s existing offerings by focusing on new and innovative approaches and methods in the medical device arena, with solutions for customers at every stage of product development. This ranges from the implementation of quality management systems and clinical validation, to helping customers achieve commercialisation and gain market access.
Erwin de Buijzer says: “I am excited to be joining such a dedicated team, committed to facilitating customers worldwide in achieving market success for their medical devices. I am keen to add my knowledge and experience to this diverse network, ensuring LINK Medical can continue supplying exceptional support to clients across the medical device industry.”
Dr. Uwe Anzenberger, General Manager at LINK Medical Germany, says: “LINK Medical’s continued growth beyond the Nordics, including the addition of Erwin to our team, will help us support our customers in Germany and beyond as they bring their medical device to market. We are excited to see what the future will hold with our strengthened capacity to help customers, regardless of their location."
About LINK Medical
LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. We offer a well-integrated local presence in the Nordics, UK, and Germany. Reaching from early phase development to post-marketing, we have over 200 employees providing expert guidance across every aspect of a project – all from ONE source. Our promise is to improve and accelerate your product development through transformative methods, active communication, and optimal solutions. As a strategic partner, we provide expert competence and technology to enable evidence-based decision-making that supports the delivery of superior clinical outcomes.